The primary issue in MCRO, Inc. v. Bandai (Fed. Cir. September 13, 2016) patent eligible subject matter for a software invention. The Federal Circuit found a claim of a patented software invention was patent eligible subject matter. Given that for the past two years, relatively few software patents were affirmed as being eligible for patent protection (i.e., patent eligible … [Read more...]
Patent eligible subject matter
Patent eligible subject matter is everything made under the sun except for abstract ideas, laws of nature and natural phenomena.
Browse related articles below.
In Bascom v. AT&T (Fed. Cir. June 27, 2016), the Court held that the ordered combination of software steps recited in the claims of the patent were eligible for patent protection (i.e., patent eligible) under Section 101. In particular, the Court found that the specific way of associating a local account and a request from the local account for filtering Internet content … [Read more...]
The case of Enfish v. MSFT (Fed. Cir. 2016) is one of the rare Section 101 case in which the Federal Circuit identified claims for software inventions as eligible for patent protection after the Supreme Court’s decision in Alice and Mayo. In this blog post, we will review why the claimed software invention was deemed eligible for patent protection while so many others software … [Read more...]
Bottom line: Patent applications directed to software inventions should be written to disclose the result and the effect of the software, but more importantly, the mechanism of the result or effect of the software. Doing so may increase the odds that the software invention will be considered to be eligible for patent protection. Nevertheless, inventors should be aware that … [Read more...]
Bottom line: Although the following patent case relating to eligibility of patent protection is set within the medical diagnostic realm, it may potentially be applicable to other technological areas. Diagnostic tests for detecting a biomarker and merely amplifying that biomarker using well known techniques are ineligible for patent protection if the biomarker is a naturally … [Read more...]